{"cursor":"4749","size":15,"audio":[],"currentlang":"en","article":"\n\n'Intrinsic activity' ('IA') or 'efficacy' refers to the relative ability of a\ndrug-receptor complex to produce a maximum functional response. This must be\ndistinguished from the affinity, which is a measure of the ability of the drug\nto bind to its molecular target, and the EC 50 , which is a measure of\nthe potency of the drug and which is proportional to both efficacy and affinity.\nThis use of the word \"efficacy\" was introduced by Stephenson (1956) to describe the way in which agonists vary in the\nresponse they produce, even when they occupy the same number of receptors. High\nefficacy agonists can produce the maximal response of the receptor system while\noccupying a relatively low proportion of the receptors in that system.\n\nAgonists of lower efficacy are not as efficient at producing a response from the\ndrug-bound receptor, by stabilizing the active form of the drug-bound receptor.\nTherefore, they may not be able to produce the same maximal response, even when\nthey occupy the entire receptor population, as the efficiency of transformation\nof the inactive form of the drug-receptor complex to the active drug-receptor\ncomplex may not be high enough to evoke a maximal response. Since the observed\nresponse may be less than maximal in systems with no spare receptor reserve,\nsome low efficacy agonists are referred to as partial agonists.\n\nHowever, it is worth bearing in mind that these terms are relative - even\npartial agonists may appear full agonists in a different system/experimental\nsetup, as when the number of receptors increases, there may be enough drug-\nreceptor complexes for a maximum response to be produced, even with individually\nlow efficacy of transducing the response. There are actually relatively few true\nfull agonists or silent antagonists; many compounds usually considered to be\nfull agonists (such as DOI) are more accurately described as high efficacy\npartial agonists, as a partial agonist with efficacy over ~80-90% is\nindistinguishable from a full agonist in most assays. Similarly many antagonists\n(such as naloxone) are in fact partial agonists or inverse agonists, but with\nvery low efficacy (less than 10%). Compounds considered partial agonists tend to\nhave efficacy in between this range.\n\n{| class=\"wikitable\" border=\"1\" style=\"text-align:center\"\n|-\n! Ligand Description colspan=\"5\" | % Efficacy (E)\n|- Full agonist Efficacy equal to the endogenous agonist style=\"border-left:0px;border-\n|right:0px;\" | E style=\"border-left:0px;border-right:0px;\" | = style=\"border-left:0px;border-\n|right:0px;\" | 100 style=\"border-left:0px;border-right:0px;\" | style=\"border-left:0px;border-\n|right:0px;\" | - Partial agonist Efficacy less than the endogenous agonist style=\"border-left:0px;border-\n|right:0px;\" | 0 style=\"border-left:0px;border-right:0px;\" | ","linknr":253,"url":"Intrinsic_activity","recorded":1376427702,"links":["/w/index.php?title=Intrinsic_activity&action=edit","/w/index.php?title=Intrinsic_activity&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Intrinsic_activity","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","/wiki/File:Efficacy_spectrum.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Efficacy_spectrum.png/320px-Efficacy_spectrum.png","/wiki/File:Efficacy_spectrum.png","//bits.wikimedia.org/static-1.22wmf8/skins/common/images/magnify-clip.png","/wiki/Drug","/wiki/Receptor_(biochemistry)","/wiki/Dissociation_constant#Protein-ligand_binding","/wiki/Half_maximal_effective_concentration","/wiki/Potency_(pharmacology)","#cite_note-pmid13383117-1","/wiki/Agonist","#cite_note-urlGlaxo_Wellcome_pharmacology_guide-2","/wiki/2,5-Dimethoxy-4-iodoamphetamine","/wiki/Naloxone","/wiki/Full_agonist","/wiki/Partial_agonist","/wiki/Receptor_antagonist#Silent_antagonists","/wiki/Inverse_agonist","/w/index.php?title=Intrinsic_activity&action=edit&section=1","/w/index.php?title=Intrinsic_activity&veaction=edit&section=1","#cite_ref-pmid13383117_1-0","http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510558","/wiki/PubMed_Central","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1510558","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/13383117","#cite_ref-urlGlaxo_Wellcome_pharmacology_guide_2-0","http://www.pdg.cnb.uam.es/cursos/Barcelona2002/pages/Farmac/Comput_Lab/Guia_Glaxo/chap2c.html","/wiki/Template:Pharmacology","/wiki/Template_talk:Pharmacology","//en.wikipedia.org/w/index.php?title=Template:Pharmacology&action=edit","/wiki/Medication","/wiki/Pharmacology","/wiki/Pharmacokinetics","/wiki/ADME","/wiki/Absorption_(pharmacokinetics)","/wiki/Distribution_(pharmacology)","/wiki/Drug_metabolism","/wiki/Excretion","/wiki/Clearance_(medicine)","/wiki/Loading_dose","/wiki/Volume_of_distribution","/wiki/Initial_volume_of_distribution","/wiki/Rate_of_infusion","/wiki/Compartment_(pharmacokinetics)","/wiki/Bioequivalence","/wiki/Bioavailability","/wiki/Onset_of_action","/wiki/Biological_half-life","/wiki/Plasma_protein_binding","/wiki/Therapeutic_index","/wiki/Median_lethal_dose","/wiki/Effective_dose_(pharmacology)","/wiki/Pharmacodynamics","/wiki/Toxicity","/wiki/Neurotoxicology","/wiki/Dose%E2%80%93response_relationship","/wiki/Efficacy#Pharmacology","/wiki/Potency_(pharmacology)","/wiki/Antimicrobial_pharmacodynamics","/wiki/Minimum_inhibitory_concentration","/wiki/Bacteriostatic_agent","/wiki/Minimum_bactericidal_concentration","/wiki/Bactericide","/wiki/Agonist","/wiki/Inverse_agonist","/wiki/Irreversible_agonist","/wiki/Partial_agonist","/wiki/Superagonist","/wiki/Physiological_agonism_and_antagonism","/wiki/Receptor_antagonist","/wiki/Competitive_antagonist","/wiki/Irreversible_antagonist","/wiki/Physiological_agonism_and_antagonism","/wiki/Binding_(molecular)","/wiki/Dissociation_constant#Protein-ligand_binding","/wiki/Binding_selectivity","/wiki/Functional_selectivity","/wiki/Drug_tolerance","/wiki/Tachyphylaxis","/wiki/Drug_resistance","/wiki/Antibiotic_resistance","/wiki/Multiple_drug_resistance","/wiki/Pharmacogenetics","/wiki/Pharmacogenomics","/wiki/Neuropsychopharmacology","/wiki/Neuropharmacology","/wiki/Psychopharmacology","/wiki/Template:Neuromodulation","/wiki/Template_talk:Neuromodulation","//en.wikipedia.org/w/index.php?title=Template:Neuromodulation&action=edit","/wiki/Neuromodulation","/wiki/Enzyme","/wiki/Enzyme_inducer","/wiki/Enzyme_inhibitor","/wiki/Ion_channel","/wiki/Channel_opener","/wiki/Channel_blocker","/wiki/Receptor_(biochemistry)","/wiki/Agonist","/wiki/Receptor_antagonist","/wiki/Positive_allosteric_modulator","/wiki/Negative_allosteric_modulator","/wiki/Inverse_agonist","/wiki/Membrane_transport_protein","/wiki/Reuptake","/wiki/Reuptake_enhancer","/wiki/Reuptake_inhibitor","/wiki/Releasing_agent","/wiki/Precursor_(chemistry)","/wiki/Cofactor_(biochemistry)","/wiki/Enzyme","/wiki/Template:Enzyme_inhibition","/wiki/Ion_channel","/wiki/Calcium_channel_blocker","/wiki/Potassium_channel_blocker","/wiki/Sodium_channel_blocker","/wiki/Potassium_channel_opener","/wiki/Receptor_(biochemistry)","/wiki/Membrane_transport_protein","/wiki/Biogenic_amine","/wiki/Monoamine_neurotransmitter","/wiki/Adrenergic","/wiki/Adrenergic_agonist","/wiki/Alpha-adrenergic_agonist","/wiki/Beta-adrenergic_agonist","/wiki/Beta1-adrenergic_agonist","/wiki/Beta2-adrenergic_agonist","/wiki/Adrenergic_antagonist","/wiki/Alpha_blocker","/wiki/Alpha-1_blocker","/wiki/Alpha-2_blocker","/wiki/Beta_blocker","/wiki/Norepinephrine_reuptake_inhibitor","/wiki/Dopaminergic","/wiki/Dopamine_agonist","/wiki/Dopamine_antagonist","/wiki/Dopamine_reuptake_inhibitor","/wiki/Histamine","/wiki/Histamine_agonist","/wiki/Histamine_antagonist","/wiki/H1_antagonist","/wiki/H2_antagonist","/wiki/H3_receptor_antagonist","/wiki/Serotonergic","/wiki/Serotonin_receptor_agonist","/wiki/Serotonin_antagonist","/wiki/5-HT3_antagonist","/wiki/Serotonin_reuptake_inhibitor","/wiki/Selective_serotonin_reuptake_enhancer","/wiki/Amino_acid","/wiki/Gamma-Aminobutyric_acid","/wiki/GABA_agonist","/wiki/GABA_antagonist","/wiki/GABA_reuptake_inhibitor","/wiki/Glutamic_acid","/wiki/Excitatory_amino_acid_agonist","/wiki/Ampakine","/wiki/Excitatory_amino_acid_antagonist","/wiki/NMDA_receptor_antagonist","/wiki/Cholinergic","/wiki/Parasympathomimetic_drug","/wiki/Muscarinic_agonist","/wiki/Nicotinic_agonist","/wiki/Anticholinergic","/wiki/Muscarinic_antagonist","/wiki/Nicotinic_antagonist","/wiki/Ganglionic_blocker","/wiki/Neuromuscular-blocking_drug","/wiki/Endocannabinoid_system","/wiki/Cannabinoid","/wiki/Cannabinoid_receptor_antagonist","/wiki/Opioid","/wiki/Opioid","/wiki/Opioid_antagonist","/wiki/Adenosine_reuptake_inhibitor","/wiki/Angiotensin_II_receptor_antagonist","/wiki/Endothelin_receptor_antagonist","/wiki/NK1_receptor_antagonist","/wiki/Vasopressin_receptor_antagonist","/wiki/Cofactor_(biochemistry)","/wiki/Template:Enzyme_cofactors","/wiki/Precursor_(chemistry)","/wiki/Template:Amino_acids","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Intrinsic_activity&oldid=497546759","/wiki/Help:Category","/wiki/Category:Pharmacology","/w/index.php?title=Special:UserLogin&returnto=Intrinsic+activity&type=signup","/w/index.php?title=Special:UserLogin&returnto=Intrinsic+activity","/wiki/Intrinsic_activity","/wiki/Talk:Intrinsic_activity","#","/wiki/Intrinsic_activity","/w/index.php?title=Intrinsic_activity&action=edit","/w/index.php?title=Intrinsic_activity&veaction=edit","/w/index.php?title=Intrinsic_activity&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Intrinsic_activity","/wiki/Special:RecentChangesLinked/Intrinsic_activity","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Intrinsic_activity&oldid=497546759","/w/index.php?title=Intrinsic_activity&action=info","/w/index.php?title=Special:Cite&page=Intrinsic_activity&id=497546759","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Intrinsic+activity","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Intrinsic+activity&oldid=497546759&writer=rl","/w/index.php?title=Intrinsic_activity&printable=yes","#","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Intrinsic_activity","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["biochemistry","pharmacology"],"pdf":[],"categories":["Pharmacology"],"headings":["References"],"image":["//upload.wikimedia.org/wikipedia/commons/thumb/b/bd/Efficacy_spectrum.png/320px-Efficacy_spectrum.png","//bits.wikimedia.org/static-1.22wmf8/skins/common/images/magnify-clip.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["receptor","biochemistry"],["potency","pharmacology"]],"members":["receptor","potency"],"related":["Drug","Receptor_(biochemistry)","Half_maximal_effective_concentration","Potency_(pharmacology)","Agonist","2,5-Dimethoxy-4-iodoamphetamine","Naloxone","Full_agonist","Partial_agonist","Inverse_agonist"]}